According to the report published by Allied Market Research, the global Cancer Immunotherapy Market generated $85.60 billion in 2020, and is estimated to generate $309.66 billion by 2030, witnessing a CAGR of 14.1% from 2020 to 2030.

The increasing prevalence of cancer and rising R&D activities in the cancer immunotherapy field is driving the demand for the market.